Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Sep;34(9):1678–1684. doi: 10.1128/aac.34.9.1678

Metabolic N-hydroxylation of pentamidine in vitro.

B J Berger 1, R J Lombardy 1, G D Marbury 1, C A Bell 1, C C Dykstra 1, J E Hall 1, R R Tidwell 1
PMCID: PMC171904  PMID: 2285279

Abstract

By using high-performance liquid chromatography, the in vitro conversion of pentamidine to the corresponding amidoximes (N-hydroxypentamidine and N,N'-dihydroxypentamidine) was studied in supernatants of rat liver homogenate centrifuged at 9,000 x g. The presence of the two amidoxime peaks in chromatograms was confirmed by liquid secondary ion mass spectrometry and by unequivocal synthesis of the suspected metabolites. The metabolic reactions were found to be catalyzed by the cytochrome P-450 system (mixed-function oxidases). The formation of the monohydroxylated product was found to have a Km of 0.48 mM and a Vmax of 29.50 pmol/min per mg of protein, while the dihydroxylated metabolite had a Km of 0.73 mM and a Vmax of 4.10 pmol/min per mg of protein. N,N'-Dihydroxypentamidine was found to have highly reduced antiprotozoal activity in vitro relative to that of pentamidine, and neither of the hydroxylated metabolites nor pentamidine was found to be significantly mutagenic by the Ames test. Contrary to previous reports, pentamidine is readily metabolized to at least two hydroxylated products, and this conversion may be relevant to the clinical use of the compound and to future drug design.

Full text

PDF
1678

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger B. J., Hall J. E., Tidwell R. R. High-performance liquid chromatographic method for the quantification of several diamidine compounds with potential chemotherapeutic value. J Chromatogr. 1989 Sep 29;494:191–200. doi: 10.1016/s0378-4347(00)82668-7. [DOI] [PubMed] [Google Scholar]
  2. Berger B. J., Hall J. E., Tidwell R. R. The distribution of multiple doses of pentamidine in rats. Pharmacol Toxicol. 1990 Mar;66(3):234–236. doi: 10.1111/j.1600-0773.1990.tb00740.x. [DOI] [PubMed] [Google Scholar]
  3. Bernard E. M., Donnelly H. J., Maher M. P., Armstrong D. Use of a new bioassay to study pentamidine pharmacokinetics. J Infect Dis. 1985 Oct;152(4):750–754. doi: 10.1093/infdis/152.4.750. [DOI] [PubMed] [Google Scholar]
  4. Boreham P. F., Phillips R. E., Shepherd R. W. The sensitivity of Giardia intestinalis to drugs in vitro. J Antimicrob Chemother. 1984 Nov;14(5):449–461. doi: 10.1093/jac/14.5.449. [DOI] [PubMed] [Google Scholar]
  5. Clement B., Raether W. Amidoximes of pentamidine: synthesis, trypanocidal and leishmanicidal activity. Arzneimittelforschung. 1985;35(7):1009–1014. doi: 10.1002/chin.198544129. [DOI] [PubMed] [Google Scholar]
  6. Clement B., Schmezer P., Weber H., Schlehofer J. R., Schmitt S., Pool B. L. Genotoxic activities of benzamidine and its N-hydroxylated metabolite benzamidoxime in Salmonella typhimurium and mammalian cells. J Cancer Res Clin Oncol. 1988;114(4):363–368. doi: 10.1007/BF02128179. [DOI] [PubMed] [Google Scholar]
  7. Clement B., Schmitt S., Zimmermann M. Enzymatic reduction of benzamidoxime to benzamidine. Arch Pharm (Weinheim) 1988 Dec;321(12):955–956. doi: 10.1002/ardp.19883211228. [DOI] [PubMed] [Google Scholar]
  8. Clement B. The N-oxidation of benzamidines in vitro. Xenobiotica. 1983 Aug;13(8):467–473. doi: 10.3109/00498258309052286. [DOI] [PubMed] [Google Scholar]
  9. Clement B., Zimmermann M. Characteristics of the microsomal N-hydroxylation of benzamidine to benzamidoxime. Xenobiotica. 1987 Jun;17(6):659–667. doi: 10.3109/00498258709043973. [DOI] [PubMed] [Google Scholar]
  10. Clement B., Zimmermann M. Hepatic microsomal N-demethylation of N-methylbenzamidine. N-dealkylation vs N-oxygenation of amidines. Biochem Pharmacol. 1987 Oct 1;36(19):3127–3133. doi: 10.1016/0006-2952(87)90622-8. [DOI] [PubMed] [Google Scholar]
  11. Clement B., Zimmermann M. Mechanism of the microsomal N-hydroxylation of para-substituted benzamidines. Biochem Pharmacol. 1988 Dec 15;37(24):4747–4752. doi: 10.1016/0006-2952(88)90347-4. [DOI] [PubMed] [Google Scholar]
  12. Conte J. E., Jr, Golden J. A. Concentrations of aerosolized pentamidine in bronchoalveolar lavage, systemic absorption, and excretion. Antimicrob Agents Chemother. 1988 Oct;32(10):1490–1493. doi: 10.1128/aac.32.10.1490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Conte J. E., Jr, Upton R. A., Phelps R. T., Wofsy C. B., Zurlinden E., Lin E. T. Use of a specific and sensitive assay to determine pentamidine pharmacokinetics in patients with AIDS. J Infect Dis. 1986 Dec;154(6):923–929. doi: 10.1093/infdis/154.6.923. [DOI] [PubMed] [Google Scholar]
  14. Desjardins R. E., Canfield C. J., Haynes J. D., Chulay J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979 Dec;16(6):710–718. doi: 10.1128/aac.16.6.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dickinson C. M., Navin T. R., Churchill F. C. High-performance liquid chromatographic method for quantitation of pentamidine in blood serum. J Chromatogr. 1985 Nov 29;345(1):91–97. doi: 10.1016/0378-4347(85)80138-9. [DOI] [PubMed] [Google Scholar]
  16. Donnelly H., Bernard E. M., Rothkotter H., Gold J. W., Armstrong D. Distribution of pentamidine in patients with AIDS. J Infect Dis. 1988 May;157(5):985–989. doi: 10.1093/infdis/157.5.985. [DOI] [PubMed] [Google Scholar]
  17. Goa K. L., Campoli-Richards D. M. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Drugs. 1987 Mar;33(3):242–258. doi: 10.2165/00003495-198733030-00002. [DOI] [PubMed] [Google Scholar]
  18. Grögl M., Oduola A. M., Cordero L. D., Kyle D. E. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure. Exp Parasitol. 1989 Jul;69(1):78–90. doi: 10.1016/0014-4894(89)90173-2. [DOI] [PubMed] [Google Scholar]
  19. Hauptmann J., Paintz M., Kaiser B., Richter M. Reduction of a benzamidoxime derivative to the corresponding benzamidine in vivo and in vitro. Pharmazie. 1988 Aug;43(8):559–560. [PubMed] [Google Scholar]
  20. IVADY G., PALDY L. Ein neues Behandlungsverfahren der interstitiellen plasmazelligen Pneumonie Frühgeborener mit fünfwertigem Stibium und aromatischen Diamidinen. Monatsschr Kinderheilkd. 1958 Jan;106(1):10–14. [PubMed] [Google Scholar]
  21. Imai Y., Ito A., Sato R. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. J Biochem. 1966 Oct;60(4):417–428. doi: 10.1093/oxfordjournals.jbchem.a128453. [DOI] [PubMed] [Google Scholar]
  22. LAUNOY L., GUILLOT M., JONCHERE H. [Study of the accumulation and the elimination of pentamidine in the mouse and the white rat]. Ann Pharm Fr. 1960 Jun;18:424–439. [PubMed] [Google Scholar]
  23. LAUNOY L., GUILLOT M., JONCHERE H. [Study of the storage and elimination of pentamidine in the mouse and white rat]. Ann Pharm Fr. 1960 May;18:273–284. [PubMed] [Google Scholar]
  24. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  25. Maron D. M., Ames B. N. Revised methods for the Salmonella mutagenicity test. Mutat Res. 1983 May;113(3-4):173–215. doi: 10.1016/0165-1161(83)90010-9. [DOI] [PubMed] [Google Scholar]
  26. Oduola A. M., Weatherly N. F., Bowdre J. H., Desjardins R. E. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp Parasitol. 1988 Jun;66(1):86–95. doi: 10.1016/0014-4894(88)90053-7. [DOI] [PubMed] [Google Scholar]
  27. Pearson R. D., Hewlett E. L. Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Ann Intern Med. 1985 Nov;103(5):782–786. doi: 10.7326/0003-4819-103-5-782. [DOI] [PubMed] [Google Scholar]
  28. Sands M., Kron M. A., Brown R. B. Pentamidine: a review. Rev Infect Dis. 1985 Sep-Oct;7(5):625–634. doi: 10.1093/clinids/7.5.625. [DOI] [PubMed] [Google Scholar]
  29. Tidwell R. R., Jones S. K., Geratz J. D., Ohemeng K. A., Cory M., Hall J. E. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J Med Chem. 1990 Apr;33(4):1252–1257. doi: 10.1021/jm00166a026. [DOI] [PubMed] [Google Scholar]
  30. Waalkes T. P., Denham C., DeVita V. T. Pentamidine: clinical pharmacologic correlations in man and mice. Clin Pharmacol Ther. 1970 Jul-Aug;11(4):505–512. doi: 10.1002/cpt1970114505. [DOI] [PubMed] [Google Scholar]
  31. Waldman R. H., Pearce D. E., Martin R. A. Pentamidine isothionate levels in lungs, livers, and kidneys of rats after aerosol or intramuscular administration. Am Rev Respir Dis. 1973 Oct;108(4):1004–1006. doi: 10.1164/arrd.1973.108.4.1004. [DOI] [PubMed] [Google Scholar]
  32. Wordell C. J., Hauptman S. P. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Clin Pharm. 1988 Jul;7(7):514–527. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES